Franz Mosthaf

680 total citations
22 papers, 320 citations indexed

About

Franz Mosthaf is a scholar working on Oncology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Franz Mosthaf has authored 22 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Infectious Diseases. Recurrent topics in Franz Mosthaf's work include Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Franz Mosthaf is often cited by papers focused on Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Franz Mosthaf collaborates with scholars based in Germany, Austria and United States. Franz Mosthaf's co-authors include Christian Hoffmann, Hartwig Klinker, Christoph Wyen, Albrecht Stoehr, Marcus Hentrich, Markus Müller, Jan Siehl, Juergen Rockstroh, Heinz‐August Horst and Hans Jaeger and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Radiotherapy and Oncology.

In The Last Decade

Franz Mosthaf

21 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz Mosthaf Germany 10 189 154 92 81 54 22 320
Hans‐Reinhard Brodt Germany 8 161 0.9× 130 0.8× 121 1.3× 145 1.8× 37 0.7× 17 347
R. Kaphan France 4 201 1.1× 113 0.7× 94 1.0× 73 0.9× 19 0.4× 7 280
Benjamin Tan United States 6 205 1.1× 138 0.9× 46 0.5× 70 0.9× 52 1.0× 9 261
Giampiero di Gennaro Italy 7 153 0.8× 110 0.7× 135 1.5× 94 1.2× 55 1.0× 11 340
Sara Nistal Spain 6 103 0.5× 127 0.8× 21 0.2× 42 0.5× 57 1.1× 8 234
Buxton Ndemera Zimbabwe 9 231 1.2× 83 0.5× 146 1.6× 113 1.4× 8 0.1× 10 306
GianPiero Cadeo Italy 6 86 0.5× 80 0.5× 167 1.8× 48 0.6× 37 0.7× 8 291
Ivy Gudza Zimbabwe 8 249 1.3× 104 0.7× 139 1.5× 96 1.2× 9 0.2× 10 296
Robert Ochai United States 3 158 0.8× 72 0.5× 90 1.0× 46 0.6× 9 0.2× 3 223
O Danne France 5 205 1.1× 78 0.5× 186 2.0× 103 1.3× 7 0.1× 10 398

Countries citing papers authored by Franz Mosthaf

Since Specialization
Citations

This map shows the geographic impact of Franz Mosthaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Mosthaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Mosthaf more than expected).

Fields of papers citing papers by Franz Mosthaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Mosthaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Mosthaf. The network helps show where Franz Mosthaf may publish in the future.

Co-authorship network of co-authors of Franz Mosthaf

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Mosthaf. A scholar is included among the top collaborators of Franz Mosthaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Mosthaf. Franz Mosthaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singer, Susanne, et al.. (2022). Awareness and use of psychosocial care among cancer patients and their relatives—a comparison of people with and without a migration background in Germany. Journal of Cancer Research and Clinical Oncology. 149(5). 1733–1745. 3 indexed citations
2.
Eßer, Stefan, Helmut Schöfer, Christian Hoffmann, et al.. (2022). S1‐Leitlinie: Kaposi‐Sarkom. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 20(6). 892–905. 2 indexed citations
3.
Heymanns, Jochen, et al.. (2022). Empfehlungen zur psychosozialen und psychoonkologischen Versorgung. 25(5). 46–55. 2 indexed citations
4.
5.
Eßer, Stefan, Helmut Schöfer, Christian Hoffmann, et al.. (2022). S1 Guidelines for the Kaposi Sarcoma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 20(6). 892–904. 9 indexed citations
6.
Werner, Ricardo Niklas, Matthew Gaskins, G. Avila Valle, et al.. (2021). State of the art treatment for stage I to III anal squamous cell carcinoma: A systematic review and meta-analysis. Radiotherapy and Oncology. 157. 188–196. 4 indexed citations
7.
Oette, Mark, Franz Mosthaf, Marie‐Luise Sautter‐Bihl, & Stefan Eßer. (2017). HIV-Associated Anal Dysplasia and Anal Carcinoma. Oncology Research and Treatment. 40(3). 100–105. 5 indexed citations
8.
Eßer, Stefan, Alexander Kreuter, Mark Oette, et al.. (2015). German‐Austrian guidelines on anal dysplasia and anal cancer in HIV‐positive individuals: prevention, diagnosis, and treatment. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 13(12). 1302–1319. 38 indexed citations
9.
Eßer, Stefan, Alexander Kreuter, Mark Oette, et al.. (2015). Deutsch‐Österreichische S2k‐Leitlinie: anale Dysplasien und Analkarzinome bei HIV‐Infizierten: Prävention, Diagnostik und Therapie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 13(12). 3 indexed citations
10.
11.
Hensel, M., Christoph Plöger, Stefan Fuxius, et al.. (2012). Excellent long-term survival of 170 patients with Waldenström’s macroglobulinemia treated in private oncology practices and a university hospital. Annals of Hematology. 91(12). 1923–1928. 8 indexed citations
12.
Hentrich, Marcus, Marcel Berger, Christoph Wyen, et al.. (2012). Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study. Journal of Clinical Oncology. 30(33). 4117–4123. 68 indexed citations
13.
Hensel, Manfred, Thomas A. Lutz, Albrecht Stoehr, et al.. (2011). HIV and Cancer in Germany. Deutsches Ärzteblatt international. 108(8). 117–22. 11 indexed citations
14.
Hensel, M., et al.. (2009). Cancer incidence in HIV-positive patients in Germany: A nation-wide survey from 2000 to 2007. Journal of Clinical Oncology. 27(15_suppl). e22115–e22115. 1 indexed citations
15.
Mosthaf, Franz, et al.. (2008). Linksschenkelblock und primärer benigner Herztumor*. DMW - Deutsche Medizinische Wochenschrift. 116(4). 134–136. 1 indexed citations
16.
Witte, S., et al.. (2008). Hepatotoxicity in patients prescribed efavirenz or nevirapine.. PubMed. 13(7). 343–8. 45 indexed citations
17.
Mosthaf, Franz, et al.. (2006). Hohe Inzidenz nicht AIDS-definierender Neoplasien bei HIV-infizierten Patienten in Deutschland. DMW - Deutsche Medizinische Wochenschrift. 131(34/35). 1849–1852. 9 indexed citations
18.
Hartmann, Martin, et al.. (2005). Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort). International Journal of STD & AIDS. 16(6). 404–409. 11 indexed citations
19.
Hartmann, Martin, et al.. (2005). Arzneimittelexantheme bei Therapie der HIV-Infektion mit Efavirenz und Nevirapin. Der Hautarzt. 56(9). 847–853. 4 indexed citations
20.
Hoffmann, Christian, Kai Uwe Chow, Eva Wolf, et al.. (2004). Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease. British Journal of Haematology. 125(4). 455–462. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans‐Reinhard Brodt Breakdown of academic impact, for papers by R. Kaphan Breakdown of academic impact, for papers by Benjamin Tan Breakdown of academic impact, for papers by Giampiero di Gennaro Breakdown of academic impact, for papers by Sara Nistal Breakdown of academic impact, for papers by Buxton Ndemera Breakdown of academic impact, for papers by GianPiero Cadeo Breakdown of academic impact, for papers by Ivy Gudza Breakdown of academic impact, for papers by Robert Ochai Breakdown of academic impact, for papers by O Danne
Rankless by CCL
2026